Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models-Reference-Cited by-同舟云学术

Immunogenicity and safety of a tetravalent E. coli O-antigen bioconjugate vaccine in animal models

Published:2016-07 Issue:35 Volume:34 Page:4152-4160
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

van den Dobbelsteen Germie P.J.M.,Faé Kellen C.,Serroyen Jan,van den Nieuwenhof Ingrid M.,Braun Martin,Haeuptle Micha A.,Sirena Dominique,Schneider Joerg,Alaimo Cristina,Lipowsky Gerd,Gambillara-Fonck Veronica,Wacker Michael,Poolman Jan T.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference47 articles.

1. Molecular mechanisms of Escherichia coli pathogenicity;Croxen;Nat Rev Microbiol,2010

2. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem;Russo;Microbes Infect Inst Pasteur,2003

3. The rapidly emerging ESBL-producing Escherichia coli O25-ST131 clone carries LPS core synthesis genes of the K-12 type;Szijártó;FEMS Microbiol Lett,2012

4. Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000–2009;Zilberberg;Infect Control Hosp Epidemiol,2013

5. Clinical characteristics and outcome of elderly patients with community-onset bacteremia;Hernández;J Infect,2015

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive characterization of bacterial glycoconjugate vaccines by liquid chromatography - mass spectrometry;Carbohydrate Polymers;2024-10

2. Safety, reactogenicity, and immunogenicity of different doses of 10-valent Extraintestinal Pathogenic Escherichia Coli (ExPEC10V) bioconjugate vaccine (VAC52416) in healthy Japanese adults aged 60 to 85 years in a randomized, double-blind, phase 1 study.;Journal of Infection and Chemotherapy;2024-09

3. Bacterial glycoengineering: Cell-based and cell-free routes for producing biopharmaceuticals with customized glycosylation;Current Opinion in Chemical Biology;2024-08

4. Vaccines against extraintestinal pathogenic Escherichia coli (ExPEC): progress and challenges;Gut Microbes;2024-06-02

5. Progress toward a vaccine for extraintestinal pathogenic E. coli (ExPEC) II: efficacy of a toxin-autotransporter dual antigen approach;Infection and Immunity;2024-05-07